Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Atara Biotherapeutics Inc shares valued at $50,289 were sold by Touchon Pascal on May 16 ’24. At $0.62 per share, Touchon Pascal sold 81,506 shares. The insider’s holdings dropped to 1,829,146 shares worth approximately $1.28 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Nguyen AnhCo sold 42,899 shares, netting a total of over 26,469 in proceeds. Following the sale of shares at $0.62 each, the insider now holds 898,498 shares.
Before that, Murugan Amar had sold 32,401 shares from its account. In a trade valued at $19,991, the EVP, Chief Legal Officer traded Atara Biotherapeutics Inc shares for $0.62 each. Upon closing the transaction, the insider’s holdings decreased to 32,401 shares, worth approximately $0.49 million.
As published in a research note from Mizuho on November 09, 2023, Atara Biotherapeutics Inc [ATRA] has been rated down from a Buy to a Neutral and the price target has been revised to $1 from $31. Analysts at H.C. Wainwright downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early November. As of November 09, 2023, Evercore ISI has decreased its “an Outperform” rating to a “an In-line” for ATRA. Earlier on July 20, 2022, Citigroup downgraded its rating. Their new recommendation was “a Sell” for ATRA stock which previously was a “a Neutral”.
Analyzing ATRA Stock Performance
During the last five days, there has been a surge of approximately 9.34%. Over the course of the year, Atara Biotherapeutics Inc shares have jumped approximately 36.47%. Shares of the company reached a 52-week high of $1.5800 on 02/02/24 and a 52-week low of $0.4323 on 01/03/24. A 50-day SMA is recorded $0.6745, while a 200-day SMA reached $0.9487. Nevertheless, trading volume fell to 0.81 million shares from 2.0 million shares the previous day.
Support And Resistance Levels for Atara Biotherapeutics Inc (ATRA)
According to the 24-hour chart, there is a support level at 0.6626, which, if violated, would cause prices to drop to 0.6254. In the upper region, resistance lies at 0.7335. The next price resistance is at 0.7672. RSI (Relative Strength Index) is 56.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0823, which suggests the price will decrease in the coming days. Percent R is at 12.29%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
